FindTrial
Sign In

Development and evaluation of new ELISA test for rapid and differential diagnosis of human brucellosis.

Development and evaluation of indirect ELISA using recombinant Omp25 protein of Brucella melitensis for rapid and differential diagnosis of human brucellosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046311
Enrollment
200
Registered
2022-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A239- Brucellosis, unspecified

Interventions

None listed

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with confirmed brucellosis

Exclusion criteria

Exclusion criteria: Unsuspected brucellosis

Design outcomes

Primary

MeasureTime frame
development of new ELISA testTimepoint: 2 years—

Secondary

MeasureTime frame
clinical utility of new ELISATimepoint: 3 years—

Countries

India

Contacts

Public ContactDr Vandana K E

Kasturba Medical College, Manipal

vandana.ke@manipal.edu9902206009

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026